MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
12.46
-0.18
-1.46%
Opening 10:32 08/19 EDT
OPEN
12.30
PREV CLOSE
12.64
HIGH
12.53
LOW
12.30
VOLUME
12.77K
TURNOVER
--
52 WEEK HIGH
18.30
52 WEEK LOW
9.77
MARKET CAP
2.17B
P/E (TTM)
120.69
1D
5D
1M
3M
1Y
5Y
1D
CICC Sticks to Its Buy Rating for HUTCHMED (China) (HCM)
TipRanks · 5h ago
Orient Securities Keeps Their Buy Rating on HUTCHMED (China) (HCM)
TipRanks · 9h ago
AstraZeneca Reports Mixed Lung Cancer Trial Outcomes From Three Pivotal Studies
Benzinga · 2d ago
At a glance: stocks gapping up premarket
Seeking Alpha · 2d ago
Weekly Report: what happened at HCM last week (0810-0814)?
Weekly Report · 2d ago
AstraZeneca: Tagrisso Plus Orpathys Phase III Trial Shows PFS, OS Improvements In EGFRm Lung Cancer
NASDAQ · 2d ago
HUTCHMED's ORPATHYS-TAGRISSO Combo Shows Significant PFS, OS Benefit In Phase III Trial
NASDAQ · 2d ago
Reported Sunday, HUTCHMED Says ORPATHYS Plus TAGRISSO Achieved Statistically Significant, Clinically Meaningful PFS And OS Improvements In MET-Driven EGFR-Mutated Lung Cancer
Benzinga · 2d ago
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.